Signal unchanged: DO NOT BUY across all three horizons (vs 31 Jul 2026, $317.29). Astera reported a strong Q2 on 4 Aug — revenue $392.4M (+104% YoY, +27% QoQ), op margin 22.7% — and guided Q3 above the Street, but the stock had already rallied ~45% into the print and sold the news (−12% on the day) before recovering to $331.50 (+4.5% since last report). Analyst targets jumped (consensus $300 → $372; median $425; now above price), yet the name is still ~2.3× its warranted multiple and the AI-concentration systemic tail remains armed with breadth narrowing — so DNB Trigger 2(b) still fires.
Astera Labs is a fabless semiconductor company that designs the high-speed connectivity that ties together the chips, memory and networking inside AI and cloud data-centre racks. Its Intelligent Connectivity Platform bundles signal-conditioning retimers (Aries), memory controllers (Leo), fabric switches (Scorpio) and gearboxes, all unified by a common software layer (COSMOS) that lets hyperscalers monitor and tune links at fleet scale. In effect it sells the plumbing that keeps GPU clusters from choking on their own data — an under-the-radar "AI capex tax collector" that earns a small toll on nearly every advanced AI rack built. Founded in 2017 and IPO'd in March 2024, it runs debt-free with ~75% gross margins, and its edge is deep design-in relationships with the largest cloud builders plus a software moat that raw component rivals lack.
Lifecycle & sector. High-growth fabless semiconductor (Information Technology / AI data-centre connectivity). Scored on growth, unit economics, gross margin, Rule-of-40 and moat — the correct lens for a hyper-growth chip designer, not trailing P/E or dividend metrics.
| Sub-signal | Value | Benchmark | Score | Read |
|---|---|---|---|---|
| Revenue trajectory | Q2 $392.4M, +104% YoY, +27% QoQ | Semis median +8–12% | 96 | Top-decile growth, still accelerating |
| Gross margin | 73.3% (Q2), 75.1% TTM | Fabless strong >60% | 90 | Premium, software-attached |
| Operating margin | 22.7% (Q2), 22.8% TTM | Expanding | 80 | Real operating leverage as it scales |
| Cash generation | FCF ~$282M recent; FCF/OCF 0.82 | >0 at this growth is rare | 85 | Self-funding hyper-growth |
| Balance sheet | Zero debt; ~$1.25B cash; current ratio 10× | Net cash | 95 | Fortress — no leverage gate risk |
| Management skin-in-game | Founder-led; SBC elevated; ~5%/yr dilution | Watch SBC | 62 | Aligned but dilutive comp |
Moat score 62/100 — real but not fortress; competition is intensifying (see below), which is why Switching Costs and Cost Advantage are trimmed rather than asserted.
| Rival | Threat type | Share trajectory (ALAB vs rival) | Moat-erosion vector |
|---|---|---|---|
| Broadcom (AVGO) | Direct merchant — PCIe/Ethernet, custom ASIC/switching giant | ALAB gaining in retimers/switches; AVGO dominant in adjacent silicon | Scale + bundling; can price/qualify against Scorpio |
| Marvell (MRVL) | Direct merchant — interconnect, custom silicon | ALAB holding/gaining in retimers | Custom-silicon relationships with same hyperscalers |
| Microchip (MCHP) + Micron | New alliance — PCIe Gen6 switches + SSDs | Emerging challenger (announced Aug 2026) | Targets exactly ALAB/AVGO switching turf |
| Hyperscaler in-house | Vertical substitution | Contained today; structural risk | Cloud builders can insource connectivity IP over time |
| Amphenol (APH) | Adjacent interconnect (physical) | Complementary more than direct | Owns the physical layer around ALAB's silicon |
ROIC & capital allocation: High incremental ROIC on a capex-light fabless model (capex <5% of revenue); debt-free; cash deployed into R&D (~35% of revenue) rather than buybacks. Capital discipline good; the dilution/SBC line is the one blemish. Quality 79/100 — up 1 from 78 on the Q2 margin/FCF step-up, capped by intensifying competition.
Warranted-Multiple Anchor (the intrinsic lens). Discount rate r = 4.63% (10-Y UST, macro 30 Jul) + 4.5% ERP + 2.0% risk add-on (beta 3.67 > 1.6) = 11.1%. Disciplined growth: g_near 18% (secular-growth cap 15% lifted toward the 20% proven-hyper-grower ceiling and flagged — ALAB genuinely compounds >40%, but consensus ~40–46% is haircut hard), g_term 3%. Two-stage warranted P/E ≈ 23× (guardrail cap 33× not binding). Actual forward P/E ≈ 52× on FY27 consensus EPS $6.35 (NTM ~55–60× cross-check). Actual ÷ warranted ≈ 2.3× → Expensive (score <40). The actual also exceeds the 33× IT guardrail on its own — double-confirmed Expensive.
| Lens | Reading | Verdict |
|---|---|---|
| Warranted anchor | ~52× vs ~23× (2.3×) | Expensive |
| FCF yield | ~0.5% (P/FCF ~205× TTM) | Very expensive |
| EV / Sales (TTM) | ~47× | Extreme |
| Own-history decile | ~7–8th (rich, though off the Jun 499 peak) | Rich |
| Clean trailing P/E (7b) | ~260× on operating-after-tax earnings | Extreme |
| FMP financial-health rating | C+ (overall 2/5; P/E, P/B, DCF sub-scores all 1) | Valuation drag |
Primary driver: hyperscaler AI/cloud infrastructure capex — ALAB earns a toll on advanced AI racks, so its fortunes track GPU-cluster build-out more than its own execution. Amazon + Microsoft alone are spending ~$80B/quarter of combined capex (Aug 2026 reporting), and ALAB is directly in that cash-flow path.
| Horizon | Read | Basis (dated) |
|---|---|---|
| Historical (25%) | Strong | Hyperscaler capex up sharply through 2025–26; ALAB revenue +104% YoY |
| Current (50%) | Strong | Q2 record; Q3 guide above Street (“beat and guided higher”, 4 Aug); demand accelerating |
| Forward (25%) | Favourable | Sustained hyperscaler capex guidance; PCIe/CXL Gen6 + scale-up fabric TAM expanding |
Driver score 80/100 — Strong Tailwind, eligible in principle to amplify a BUY to STRONG BUY. It does not do so here: the base signal is not a BUY, and Economic-Alignment pressure is a Headwind, so no amplification fires.
Macro report (30 Jul 2026): regime “Stagflation-lite”; US Tech / XLK signals Short N, Medium U, Long O. Anchoring on the Medium horizon, the economic pressure on a rich, high-beta AI name is a HEADWIND (policy-tight into cooling growth; the AI-concentration tail armed with narrowing breadth). Buying ALAB here is Contrarian — fighting the macro pressure — and the fade is poorly justified: valuation is Expensive (no washout) and the driver, though strong, is the very trade the tail unwinds. Conviction 38. Because the pressure is a Headwind, no STRONG-BUY amplification is possible; the pressure instead corroborates the downside. Long-horizon XLK is O, so the multi-year economic backdrop is supportive — but that does not rescue the entry price.
Source: sector-map (XLK) · Macro report 2026-07-30
Risk-reward. The stock ran ~+45% into the print ($249 low 28 Jul → $362 on 3 Aug), then fell on results (−12% intraday 4 Aug) despite a beat-and-raise — the rally came first. It has since recovered to $331.5 (intraday ~$341 on 7 Aug). Daily ATR ~$38 (~11% of price) and beta 3.67 make position-risk severe: a logical stop below $289 support is ~13% / ~1.1 ATR away, but daily swings routinely exceed that.
| Signal | Reading | Score |
|---|---|---|
| MTF confluence | Monthly/Weekly uptrend, hourly strong; daily weakening (below 50-DMA $357.6), tool tag “strongly_bullish” | 66 |
| Relative strength | +60%+ vs SPY over 3mo (huge), but −20% over 1mo (post-peak) | 55 |
| RSI (daily) | 50 — neutral | 50 |
| MACD (daily) | Negative but histogram turning up (+3.98) | 52 |
| Catalyst density | Earnings passed (4 Aug); next 3 Nov — calendar clearer | 60 |
Sentiment: all analyst actions post-print were maintains (no upgrades/downgrades in 30d); targets raised; news tone constructive but flags premium valuation (Simply Wall St: “above fair value”). Timing 55/100 — mixed. The trend structure is not bearish, but this is not a clean, low-risk entry tape, and timing does not rescue an Expensive name under a triggering systemic tail.
| Date | Event | Impact | Forecast | Previous | Relevant? | Why |
|---|---|---|---|---|---|---|
| 2026-08-07 | Non-Farm Payrolls / Unemployment (Jul) | High | 80k / 4.2% | 57k / 4.2% | ⚠️ Indirect | Growth-stock risk appetite via rate path |
| 2026-08-12 | CPI YoY (Jul) | High | 3.4% | 3.5% | ⚠️ Indirect | Long-duration tech valuations rate-sensitive |
| 2026-08-13 | PPI MoM (Jul) | High | 0.1% | -0.3% | ⚠️ Indirect | Inflation → rate path |
| 2026-08-19 | FOMC Minutes | High | — | — | ⚠️ Indirect | Rate-path read for high-multiple names |
| 2026-08-26 | Core PCE MoM (Jul) | High | 0.3% | 0.1% | ⚠️ Indirect | Fed's preferred gauge |
| Date | Event | Actual | Forecast | Surprise | Impact |
|---|---|---|---|---|---|
| 2026-08-03 | ISM Manufacturing PMI (Jul) | 55.6 | 54.0 | +3.0% above | Mild risk-on |
| 2026-08-05 | ISM Services PMI (Jul) | 54.1 | 54.5 | -0.7% below | Neutral |
| 2026-08-05 | ISM Services Prices (Jul) | 70.3 | 65.0 | +8.2% above | Sticky-inflation flag — rate headwind |
ALAB is a low-macro-sensitivity name idiosyncratically — no single release moves it — but as a long-duration, high-beta AI stock its valuation is acutely rate-sensitive. The CPI (12 Aug) and Core PCE (26 Aug) prints, plus the hot ISM services-prices read, are the macro channel most likely to hit the multiple. None is a scheduling trigger (low direct sensitivity); the driver of the next re-rate is the earnings/valuation setup, not a dated macro event.
| Timeframe | Trend | Direction | RSI | MACD | Key S/R | Breakout | Vol |
|---|---|---|---|---|---|---|---|
| Monthly | Uptrend ↑ | Bullish | 63.5 | n/a | S: 131 / R: 262–499 | Resist. breakout | 0.3× |
| Weekly | Uptrend ↑ | Bullish | 58.6 | +, hist -2.9 | S: 148–189 / R: 263–499 | Resist. breakout | 1.1× |
| Daily | Weakening → | Neutral | 50.1 | -, hist +4.0 (turning) | S: 303–316 / R: 372–441 | Support breakdown | 1.0× |
| Hourly | Strong up ↑ | Bullish | 58.4 | +, rising | S: 308–324 / R: 343–406 | Resist. breakout | — |
| 15-min | Uptrend ↑ | Bullish | 60.0 | +, rising | S: 328–331 / R: 342–345 | Resist. breakout | 0.4× |
| Confluence: Strongly Bullish (higher-TF), daily transitional · MTF Score 66 | |||||||
Monthly and weekly trends are intact uptrends and the tool reads confluence as strongly bullish, driven by the higher timeframes and a sharp post-selloff hourly bounce. The daily is the caveat: price ($331.5) is below a falling 50-DMA ($357.6) with a recent support-breakdown tag, though the MACD histogram is turning up. Net: a recovering but transitional tape inside a larger uptrend — not a breakdown, but not a confirmed, low-risk trend entry either. Key level: reclaim of the daily 50-DMA (~$358) would confirm; loss of $303–$289 support opens the July lows.
ALAB daily, Apr–Aug 2026. The parabola to the $499 ATH (late Jun), the July de-rate to ~$250, and the pre-earnings bounce back to ~$362 that then sold the 4 Aug print. Price sits below a falling 50-DMA.
AI capex boom sustains, ALAB keeps compounding >40% and takes share in Scorpio switches + Gen6 fabric; the market keeps paying a ~70–75× forward multiple. Reaches the Street high ($500, +51%). Requires the AI-concentration trade to stay intact and breadth to broaden — i.e. the armed tail to disarm.
The most probable path: strong revenue growth continues but the rich multiple caps returns — earnings compounding is offset by modest de-rating, leaving the stock roughly flat over 12 months (~$340). This is the probability-weighted centre of gravity, and it says even the central case pays you little for the risk at this entry price.
The armed AI-concentration tail triggers (AI private-valuation markdown / hyperscaler capex guide-down / non-operating gains reversing) and drags the whole cohort into an index-level de-rating: ALAB's forward multiple compresses ~58× → ~30×, a ~44% move to ~$185 — amplified by its 3.67 beta. Competitive share pressure (AVGO / MRVL / MCHP-Micron Gen6 switches, hyperscaler in-housing) or an estimate cut deepens it. This downside dwarfs the base-case upside.
Forecast: Fundamental: Unlikely in the near term — price would need to fall ~56% to ~$146, or estimates roughly double, to clear a disciplined fair value; only the Bear scenario gets there. Technical: Moderate/2–4 weeks IF the stock reclaims the ~$358 50-DMA on volume; at $331.5 it is ~8% below, and the 50-DMA is falling, so a reclaim needs a fresh leg up. Catalyst: event-dependent — next real catalyst is Q3 earnings 3 Nov; a beat-and-hold reaction (unlike the 4 Aug sell-off) would open the Catalyst path. Even a met Technical/Catalyst path would not lift the signal above HOLD while the Valuation-Ceiling gate and the triggering AI tail stand — the entry rules are moot under DO NOT BUY and are shown for completeness / for the day the valuation resets.
Forecast: Not applicable — the framework is not long the name (signal DO NOT BUY). The Thesis-Invalidation conditions double as the watch-list of what would deepen the Bear case if you did hold.
Imagine you buy at $331.5 today. What you're risking: the AI-concentration tail is armed and triggering (breadth narrowing) — a cohort de-rating takes the forward multiple from ~58× toward ~30× (~$185, −44%), amplified by a 3.67 beta; you'd also be buying above a falling 50-DMA, into a name that just sold its own beat-and-raise, and no entry rule is met. What you're gaining: exposure to an elite, debt-free, ~75%-margin AI-capex toll-taker with rising analyst targets ($354–$425) and a legitimate +51% bull to $500 — but you're paying ~52× forward for it, so you collect almost no FCF yield (~0.5%) while you wait. Read: the expected value is roughly flat with a deeply asymmetric downside — acting now is not worth it; the business is a keep-watching, the price is not.
Imagine you stay out (or trim) at $331.5. What you're giving up: the +51% bull to $500 and the base's roughly-flat participation in a structurally growing AI franchise. What you're protecting: capital against the −44% bear that a triggering AI-concentration unwind would inflict on a 3.67-beta name at 52× forward. No exit rule is mechanically firing (you're not long); this is simply a do-not-enter zone. Read: for a name this expensive under a live systemic tail, staying out is the higher-EV choice until the valuation resets or breadth broadens (the tail disarms).
Position sizing not computed — no risk budget or portfolio role was specified, and the signal is DO NOT BUY, so there is no entry to size. For context: at beta 3.67 and daily ATR ~11% of price, ALAB behaves like ~3.7× the market's risk per dollar — any eventual position (post-reset) should be sized to that volatility, not to a normal equity slot.
{
"ticker": "ALAB",
"date": "2026-08-07",
"version": "v6",
"brand": "Astera Labs",
"company": "Astera Labs, Inc.",
"currency": "USD",
"exchange": "NASDAQ",
"exchange_ticker": "NASDAQ:ALAB",
"isin": "US04626A1034",
"api_ticker": "ALAB",
"finder_ticker": "ALAB",
"finder_exchange": "NASDAQ",
"analysis_status": "on-going",
"user_context": {
"horizon": null,
"allocation_pct": null,
"portfolio_role": null
},
"user_horizon": null,
"user_allocation_pct": null,
"portfolio_role": null,
"lifecycle_stage": "high-growth",
"sector": "Information Technology",
"sub_industry": "Semiconductors \u2014 AI data-center connectivity",
"price_at_rating": 331.5,
"signal_short": "DO_NOT_BUY",
"signal_medium": "DO_NOT_BUY",
"signal_long": "DO_NOT_BUY",
"primary_signal": "DO_NOT_BUY",
"short_hold_reason": "expensive",
"short_entry_confirmed": false,
"short_cap_reason": "Base composite is not a BUY; Gate 3 Valuation-Ceiling caps at HOLD; DNB Trigger 2(b) then overrides to DO NOT BUY (Expensive + triggering AI-concentration tail); neither Technical nor Catalyst entry group met",
"quality_score": 79,
"quality_detail": {
"industry_benchmark_name": "Rule of 40 (semis growth+FCF)",
"industry_benchmark_value": 132,
"industry_benchmark_score": 88,
"moat_score": 62,
"roic_percentile_vs_peers": 85,
"capital_allocation": 72,
"management_skin_in_game": 62
},
"valuation_score": 33,
"valuation_detail": {
"fcf_yield": 0.49,
"implied_growth_rate": 37.0,
"consensus_growth_rate": 43.0,
"historical_valuation_decile": 7
},
"warranted_multiple": 23.0,
"actual_multiple": 52.0,
"val_multiple_basis": "forward P/E \u2014 FY27 consensus EPS $6.35 (NTM ~55-60x cross-check)",
"discount_rate_r": 11.13,
"risk_free_10y": 4.63,
"g_near": 18.0,
"g_term": 3.0,
"warranted_ratio": 2.26,
"val_band": "expensive",
"timing_score": 55,
"timing_detail": {
"mtf_confluence": 66,
"risk_reward_score": 48,
"relative_strength_vs_spy": 61.0,
"relative_strength_vs_sector": 55.0,
"catalyst_clustering_score": 60,
"dynamic_macro_weight": 0.15
},
"driver_score": 80,
"driver_label": "Strong Tailwind",
"driver_commodity_trend": null,
"nonop_pct_of_net_income": 40.0,
"clean_pe": 260.0,
"clean_peg": null,
"competitive_share_trajectory": "gaining",
"competitive_threat_level": "elevated",
"economic_alignment_stance": "Contrarian",
"economic_alignment_conviction": 38,
"economic_alignment_pressure": "Headwind",
"economic_alignment_source": "sector-map",
"macro_report_date": "2026-07-30",
"overall_confidence": 55,
"fair_value_est": 146.0,
"stop_loss": 289.0,
"target_price": 340.0,
"scenario_base_target": 340,
"scenario_bull_target": 500,
"scenario_bear_target": 185,
"analyst_consensus_target": 372.27,
"analyst_target_high": 500.0,
"analyst_target_low": 153.0,
"analyst_target_median": 425.0,
"analyst_target_upside_pct": 12.3,
"analyst_grades_consensus": "Buy",
"analyst_bullish_pct": 72.2,
"analyst_coverage_count": 22,
"fmp_rating": "C+",
"fmp_overall_score": 2,
"recent_upgrades_30d": 0,
"recent_downgrades_30d": 0,
"entry_groups_met": 0,
"entry_conviction": "Wait",
"exit_groups_live": 0,
"exit_action": "Hold",
"hard_gate_state": "donotbuy",
"gates_triggered": [
"Valuation Ceiling"
],
"gates_caution": [
"Accounting / Dilution"
],
"do_not_buy_triggers": [
"Trigger 2 (Valuation Extreme) arm (b): Expensive band (~52x FY27 / ~58x NTM vs ~23x warranted, 2.3x) + AI-concentration systemic tail TRIGGERING (armed with breadth narrowing \u2014 RSP flat while XLK ripped +5.5%), genuine cohort member"
],
"dnb_trigger2_armed": true,
"dnb_trigger2_fired": true,
"dnb_trigger2_note": "arm (b) FIRES: Expensive + genuine AI cohort + macro tail armed AND triggering (breadth NARROWING per macro 30 Jul, not broadening) -> overrides capped HOLD to DO NOT BUY. Distinct from the 20 Jul AMZN/GOOGL/NVDA HOLD case where breadth was broadening (RSP beating SPY, tail not triggering). Consistent with the prior 16 Jul & 31 Jul ALAB reports.",
"next_update_date": "2026-08-21",
"next_update_basis": "default +14d (no impactful dated catalyst; Q3 earnings 2026-11-03 beyond the 14d window)",
"next_check_date": "2026-08-21"
}
DO NOT BUY across all three horizons, unchanged from 16 Jul and 31 Jul. Quality 79 (+1), Valuation 33 (+4, targets now above price but still Expensive), Timing 55 (+3, post-earnings recovery), Driver 80, Econ-Alignment 38 (Contrarian/Headwind). The call rests on DNB Trigger 2(b): Expensive band × a triggering (not merely armed) AI-concentration tail × genuine cohort membership.